Loading...
Market
Country taking strongest legal action against Hubei Aoks Bio-Tech by November 2025?
2
Resolution / Starting Odds
United States • 25%
China • 25%
European Union • 25%
Other • 25%
International legal news and government announcements
Story
DOJ Indicts Hubei Aoks Bio-Tech for Exporting Fentanyl Precursors and Xylazine
Nov 9, 2024, 07:05 PM
The U.S. Department of Justice has charged Hubei Aoks Bio-Tech Co. Ltd., a Wuhan-based chemical company, with exporting illegal fentanyl precursors and adulterants. The company, along with its director and three senior employees, faces a 13-count federal grand jury indictment. The charges include conspiracy to manufacture and distribute fentanyl and the introduction of misbranded drugs into interstate commerce. The indictment alleges that from November 2016 to November 2023, the company sold significant amounts of fentanyl precursors to customers in the United States. Additionally, the company is accused of manufacturing and distributing xylazine, a drug known for its flesh-eating effects, often referred to as a 'zombie drug'.
View original story
Similar markets
Issue Fines • 25%
Mandate Safety Improvements • 25%
Shut Down Operations • 25%
Other • 25%
BGI Group • 25%
China National GeneBank • 25%
Beijing Genomics Institute • 25%
Other • 25%
Implement new safety protocols • 25%
Voluntary shutdown of operations • 25%
Legal action or settlement • 25%
No significant action • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
European Union • 25%
China • 25%
India • 25%
Other • 25%
New Legislation Introduced • 25%
Existing Legislation Amended • 25%
No Action Taken • 25%
Other • 25%
United States • 33%
United Kingdom • 33%
Canada • 33%
China • 25%
India • 25%
Turkey • 25%
Other • 25%
Guilty of all charges • 25%
Guilty of some charges • 25%
Not guilty • 25%
Case dismissed • 25%